Author

Jiaojiao Yu

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID 0009-0004-3904-3822Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Bing CuiiD· 1 shared Hongyu Yuan· 1 shared Jianli LiuiD· 1 shared Jichao ZhouiD· 1 shared Jinmei YuiD· 1 shared Ning XuiD· 1 shared Pengyue Liu· 1 shared Pingping LiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bing CuiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 15, 2025

Targeting Non-Catalytic Sites of SRC Sensitizes the Efficacy of SRC Kinase Inhibitors in Solid Tumors

Jinmei Yu, Xusheng Wang, Pengyue Liu…·Bing Cui

This study identifies non-catalytic SRC functions as a mechanism of resistance to SRC kinase inhibitors and presents TS1-2 as a peptide that enhances inhibitor efficacy in solid tumors.

1 citation

humanproteomics

𝕏 PostBluesky